Clinical Trial Update: Photochemical Tissue Passivation Treatment of Saphenous Vein Grafts in CABG [NA]

View source ↗

Summary

Clinical trial update on Photochemical Tissue Passivation treatment of saphenous vein grafts in coronary artery bypass grafting, sponsored by DurVena, Inc., cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Photochemical Tissue Passivation (photochemical tissue passivation)

Snippet

Sponsor: DurVena, Inc. | Conditions: Coronary Artery Disease | NA | Status: ACTIVE_NOT_RECRUITING